BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Murata A, Okamoto K, Mayumi T, Muramatsu K, Matsuda S. Observational study to compare antithrombin and thrombomodulin for disseminated intravascular coagulation. Int J Clin Pharm 2015;37:139-47. [PMID: 25515615 DOI: 10.1007/s11096-014-0052-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Umemura Y, Yamakawa K, Hayakawa M, Kudo D, Fujimi S. Concomitant Versus Individual Administration of Antithrombin and Thrombomodulin for Sepsis-Induced Disseminated Intravascular Coagulation: A Nationwide Japanese Registry Study. Clin Appl Thromb Hemost 2018;24:734-40. [PMID: 29471674 DOI: 10.1177/1076029618755948] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
2 Okamoto K, Tamura T, Sawatsubashi Y. Sepsis and disseminated intravascular coagulation. J Intensive Care. 2016;4:23. [PMID: 27011792 DOI: 10.1186/s40560-016-0149-0] [Cited by in Crossref: 65] [Cited by in F6Publishing: 59] [Article Influence: 10.8] [Reference Citation Analysis]
3 Iba T, Thachil J. Present and future of anticoagulant therapy using antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation: a perspective from Japan. Int J Hematol. 2016;103:253-261. [PMID: 26588929 DOI: 10.1007/s12185-015-1904-z] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 5.7] [Reference Citation Analysis]
4 Giustozzi M, Ehrlinder H, Bongiovanni D, Borovac JA, Guerreiro RA, Gąsecka A, Papakonstantinou PE, Parker WAE. Coagulopathy and sepsis: Pathophysiology, clinical manifestations and treatment. Blood Rev 2021;:100864. [PMID: 34217531 DOI: 10.1016/j.blre.2021.100864] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Nogami K, Muraki I, Imano H, Iso H. Risk of disseminated intravascular coagulation in patients with type 2 diabetes mellitus: retrospective cohort study. BMJ Open 2017;7:e013894. [PMID: 28122835 DOI: 10.1136/bmjopen-2016-013894] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
6 Zhang C, Wang H, Yang H, Tong Z. Recombinant human soluble thrombomodulin and short-term mortality of infection patients with DIC: a meta-analysis. Am J Emerg Med 2016;34:1876-82. [PMID: 27452884 DOI: 10.1016/j.ajem.2016.06.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
7 Yamaguchi T, Kitajima Y, Miyauchi Y, Izawa K, Tanaka M, Hirata M, Sadatsuki Y, Ogawa Y. Assessment of bleeding in patients with disseminated intravascular coagulation after receiving surgery and recombinant human soluble thrombomodulin: A cohort study using a database. PLoS One 2018;13:e0205146. [PMID: 30296304 DOI: 10.1371/journal.pone.0205146] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
8 Pereyra D, Offensperger F, Klinglmueller F, Haegele S, Oehlberger L, Gruenberger T, Brostjan C, Starlinger P. Early prediction of postoperative liver dysfunction and clinical outcome using antithrombin III-activity. PLoS One 2017;12:e0175359. [PMID: 28406940 DOI: 10.1371/journal.pone.0175359] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]